Nabriva Therapeutics PLC (NASDAQ:NBRV)
| 1.41 Delayed Data As of 3:59pm ET |  -0.07 / -4.73%Today’s Change | 1.16 Today|||52-Week Range 3.27 | +6.82% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $147.0M |
Company Description
Nabriva Therapeutics Plc is a clinical stage biopharmaceutical company, which engages in the research and development of novel antibiotics to treat serious infections. Its product pipeline includes Lefamulin, CONTEPO, and BC-7013. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
Contact Information
Nabriva Therapeutics Plc 25-28 North Wall Quay Dublin Dublin 1 |
Employees
Shareholders
| Mutual fund holders | 9.95% |
| Other institutional | 18.00% |
| Individual stakeholders | 11.97% |
Top Executives
| There are no executives to display. |
